ArticleACS medicinal chemistry letters2020

Novel HIV-1 Protease Inhibitors with Morpholine as the P2 Ligand to Enhance Activity against DRV-Resistant Variants.

Mei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.